Global Sickle Cell Disease Market


  • Type: Common Disease Area
  • Published : March 2021
  • Region: Worldwide
  • Country: Other
  • Report ID : 169

  • Format: PPT, PDF

Global Sickle Cell Disease Market – Growth, Trends, And Forecasts (2019 – 2028)


Report Overview

The global sickle cell drugs market size stood at USD 1.35 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period

The global market for sickle cell disease treatment has been expanding alongside the growing need for treating diseases related to blood plasma. Deficiency of hemoglobin can lead up to several bodily disorders, and hence, it is important to treat sickle cell disease. Medical practitioners recommend swift treatment procedures for patients whose hemoglobin levels are low. This factor is projected to accelerate the growth of the global sickle cell disease treatment market in the years to come. The global sickle cell disease treatment market is anticipated to attract investments from new avenues over the forthcoming years. The global sickle cell disease treatment market is plush with growth opportunities, and the vendors in this market are poised to make use of these opportunities. The primary concern within the global sickle cell disease treatment market is the unpopular nature of this disease amongst the masses. Henceforth, several awareness campaigns about hemoglobin deficit have been launched via hospitals

Market Growth Drivers

The sickle cell disease market is driven by the increasing prevalence of sickle cell disease in developed, developing as well as underdeveloped economies. In addition, the availability of high unmet needs, increasing product pipeline for treating sickle cell anemia expected to create high demand for these treatment options. The sickle cell anemia treatment market is driven by increasing governments and regulatory bodies support by means of research and development investment, fast track approval for discovering newer treatments for this disorder. Better reimbursement policies and awareness of sickle cell diseases have affected the growth of market




1. Global Sickle Cell Disease Market Overview…………………………………………….
A. Market Size
2. Market Growth Drivers………………………………………………………………………………
A. Rise in Global Prevalence of Sickle Cell Disease
B. Growing R&D Investments and Reimbursement Policies
3. Major Sickle Cell Disease Diseases
C. HbS beta-thalassemia
D. Sickle Cell Trait
4. Sickle Cell Disease Market Segmentation…………………………………………………
A. Drug Class
I. Hydroxyurea (Hydrea)
I. L-glutamine oral powder (Endari)
II. Voxelotor (Oxbryta)
III. Crizanlizumab-tmca
IV. Others
B. Distribution Channel
I. Hospital
II. Pharmacies
III. Others
C. Geography
I. North America Market Analysis
II. Europe Market Analysis
III. Asia-Pacific Market Analysis
IV. Middle-East and Africa Market Analysis
5. Sickle cell Disease Major Drugs Market Share………………………………………….
A. Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape…………………………………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles…………………………………………………………………………………….
A. Novartis AG Company overview, Product & Services, Strategies & Financials
B. Global Blood Therapeutics Inc. Company overview, Product & Services, Strategies & Financials
C. Addmedica Company, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape……………………………………….
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth…………………………………………………………………….
A. New Trends and Development of Sickle cell drug market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Drug Class:

The global anemia drugs market has been segmented based on anemia type which comprises iron deficiency anemia, sickle cell anemia, aplastic anemia, hemolytic anemia pernicious anemia, and others

By Disease Indication:

Based on disease indication, the global sickle cell drugs market can be segmented into HbSS, HbSC, HbS beta-thalassemia, and sickle cell trait. HbSS and HbSβ0 are the most severe forms of SCD, while HbSC and HbSβ+ are generally milder diseases

By Distribution Channel:

On the basis of distribution channels, the market for cardiovascular drugs can be segmented into hospital pharmacies, retail pharmacies, online pharmacies, and others. The hospital segment is expected to dominate the market throughout the forecast period. VOC is the main reason for hospital admissions, leading to several visits of patients to hospitals every year. This is expected to favor the expansion of the hospital segment in the coming years. The increasing number of clinics is propelling the growth of the specialty clinics segment

By Region:

North America is expected to dominate the overall sickle cell drug market throughout the forecast period. Improving access to sickle cell disease treatment, potential pipeline candidates, and strong government support contribute to the expanding market in the U.S. Favouring reimbursement policies and the increasing number of births with SCD are prominent reasons responsible for the second position of Europe in the global market. The highest prevalence of SCD is reported in Africa, the Middle East, Latin America, and the Mediterranean regions. This is one of the primary reasons for the healthy growth of the market for the rest of the world

Top 5 Major Players

The Sickle Cell Disease Treatment market appears to be fragmented and with the presence of several companies including Novartis and Pfizer, the competitive environment is quite intense. Factors such as the high prevalence of sickle cell disease and the strong pipeline of drugs will provide considerable growth opportunities to sickle cell disease treatment manufactures. ADDMEDICA, Bristol-Myers Squibb, Emmaus Medical, Novartis, and Pfizer are some of the major companies

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements